Not finding it? Sign in to also search OpenAlex live.
-
Health-Related Quality of Life in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma: Data from the Perseus Trial of Subcutaneous Daratumumab Combined with Bortezomib, Lenalidomide, and Dexamethasone (D-VRd)
Pieter Sonneveld, Meletios Athanasios Dimopoulos, Mario Boccadoro, Hang Quach, Phoebe Joy Ho, Meral Beksaç, +38 more
1citations -
eGFR Decline in Patients with IgA Nephropathy Treated with Nefecon or Placebo: Results from the 2-Year NefIgArd Phase 3 Trial2023 Journal of the American Society of Nephrology conference-abstract Medicine Renal Diseases and Glomerulopathies
Richard A. Lafayette, Jens Halkjaer Kristensen, Andrew M. Stone, Jürgen Floege, Vladimı́r Tesař, Hernán Trimarchi, +6 more
0citations -
Phase II assessment of carboplatin with etoposide and high-dose ifosfamide in rEECur, an international randomised controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma (RR-ES).
Martin G. McCabe, Laura Kirton, Maria Khan, Sandra J. Strauss, Claudia María Valverde, C. Mata Fernández, +13 more
0citations -
Health-related quality of life (HRQoL) in patients with newly diagnosed multiple myeloma (NDMM) eligible for transplantation and treated with isatuximab, lenalidomide, bortezomib, and dexamethasone (Isa-RVd) versus rvd alone: Results from part 1 of the GMMG-HD7 study
Roland Schroers, Lisa Beatrice Leypoldt, Christof Scheid, Evgenii Shumilov, Christoph Lutz
0citations -
Abstract 416: Atorvastatin Versus Placebo In Icu Patients With Covid19: Ninety-day Results Of The INSPIRATION-S Trial2023 Arteriosclerosis Thrombosis and Vascular Biology conference-abstract Medicine COVID-19 Clinical Research Studies
Azita H. Talasaz, Parham Sadeghipour, Babak Sharif-Kashani, Farid Rashidi, Mohammad Taghi Beigmohammadi, Keivan Gohari Moghadam, +40 more
0citations -
Abstract A016: Identification of methylated regions in ductal carcinoma in situ and association with disease progression2022 Cancer Prevention Research conference-abstract Biochemistry, Genetics and Molecular Biology Epigenetics and DNA Methylation
Vandna Shah, Maria Roman-Escorza, Karen Clements, Lennart Mulder, Esther H. Lips, Jelle Wesseling, +3 more
0citations -
Adaptation measures to support decision-making in delivering a resilient built environment2025 conference-abstract Environmental Science Sustainability and Climate Change Governance Open access
Carmela Apreda, Guglielmo Ricciardi, Alfredo Reder, Paola Mercogliano, Rania Christoforou, Mina Moayedi, +4 more
0citations -
Assessment of risk of overall and late distant recurrence by Breast Cancer Index in postmenopausal women with early-stage, HR+ breast cancer in the TEAM trial.2023 Journal of Clinical Oncology conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
John M.S. Bartlett, Keying Xu, Jenna Wong, Gregory R. Pond, Yi Zhang, Melanie Spears, +12 more
1citations -
Interindividual HLA Evolutionary Divergence in Single HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation for Malignant Hematological Disorders: A Report on Behalf of the Cellular Therapy and Immunobiology Working Party of the EBMT
Simona Pagliuca, Jarl Mooyaart, Nicolaus Kröger, Jürgen Finke, Victoria T. Potter, Peter Dreger, +22 more
0citations -
Phase III assessment of topotecan and cyclophosphamide and high-dose ifosfamide in rEECur: An international randomized controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma (RR-ES).
Martin G. McCabe, Laura Kirton, Maria Khan, Nicola Fenwick, Sandra J. Strauss, Claudia María Valverde, +13 more
46citations -
Abstract 4360415: Small, Dense LDL-C and Conventional LDL-C Similarly Predict Cardiovascular Risk and Benefit of Alirocumab in Statin-Treated Patients With Recent Acute Coronary Syndrome
Gregory G. Schwartz, Michael J. Szarek, Christa M. Cobbaert, Markus Schwertfeger, Deepak L. Bhatt, Vera Bittner, +9 more
0citations -
Abstract PO5-01-11: Breast Cancer Index and comparative analysis of late distant recurrence risk with results from the TEAM trial2024 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
John M.S. Bartlett, Yi Zhang, Gregory R. Pond, Jenna Wong, Keying Xu, Melanie Spears, +14 more
0citations
17 results